Zydus Lifesciences enters exclusive negotiations to acquire majority stake in Amplitude Surgical

Zydus Lifesciences entered exclusive negotiations to acquire 85.6% of Amplitude Surgical at €6.25 per share, valuing the block at €256.8 million, with a mandatory tender offer for remaining shares.

“Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical, France, at a price of €6.25 per Amplitude Surgical share.”businesswire.com

• 1 source
• businesswire.comZydus Enters Exclusive Negotiations with PAI Partners and Other Shareholders to Acquire a Majority stake in Amplitude Surgical, FranceMar 11, 2025

Summarized from public sources; check the original articles before acting on it.